What are the terms of payment and lead time?

Terms of payment include LC, T/T, and D/P. The average lead time is 1-3 months for both peak season and off-season.

What is the company's history and scale?

Reyoung Pharmaceutical Co., Ltd. was established in 1966. It has three main factories covering an area of 1,000,000 square meters, with more than 5000 staff members and total assets of more than 1.5 billion USD.

High Quality Cefazolin Sodium for Injection

Name: High Quality Cefazolin Sodium for Injection
Brand: Reyoung Pharmaceutical Co., Ltd.
SKU: 1943695582

Shandong, ChinaReyoung Pharmaceutical Co., Ltd.

Negotiable

50,000 vial

Product profile

Customization

Available

Application

Internal Medicine

Usage Mode

for Injection

Model NO.

0.5g 1.0g

Suitable for

Elderly, Children, Adult

State

Solid

Shape

Powder

Type

Organic Chemicals

Pharmaceutical Technology

Chemical Synthesis

Drug Reg./Approval No.

Lu20160062

Drug Ad Approval No.

Lu20160062

Certificate

GMP, SGS, ISO

Transport Package

10vials/Tray/Box, 50vials/Tray/Box.

Specification

0.25g, 0.5g, 1.0g

Trademark

Reyoung

Origin

China Reyoung

HS Code

3003909090

Production Capacity

5million Vials/Year

Key features

Broad Clinical Application: Treats respiratory, urinary, skin, bone infections, septicemia, and serves as surgical prophylaxis.

Massive Production Capacity: Annual output of 2.5 billion vials of powder for injection and 2000 tons of API.

Global Market Presence: Products exported to over 70 countries across Asia, South America, Africa, CIS, Middle East, and Europe.

Strict Quality Certifications: Certified by GMP, ISO9001, ISO14001, OHS18001, SGS, and passed inspections in Colombia, Peru, etc.

Established Manufacturer: Leading Chinese pharmaceutical manufacturer established in 1966 with over 20 years of international experience.

Advanced Manufacturing Facilities: Three main factories covering 1,000,000 sqm with 30 workshops and advanced equipment like Lyophilization Machines.

Customization Services: Offers OEM and ODM services with certificates including GMP, SGS, and ISO available for customization.

Award-Winning Enterprise: Recognized as a state-focused high-tech enterprise and national contract-stressing enterprise in China.

Company profile

Reyoung Pharmaceutical Co., Ltd.

Shandong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2020-10-13 CertifiedNearest Port: Qingdao PortAverage Response Time: ≤24h CertifiedTerms of Payment: LC, T/T, D/P

AI-Powered supplier vetting

SummaryReyoung Pharmaceutical Co., Ltd. is a China-based limited company established in 1998, with 4,950 employees and operations in Shandong. The available information identifies it as a pharmaceutical manufacturer supplying injectable antibiotics, oral solid medicines, veterinary cefotaxime sodium sterile, and lyophilized products. It reports more than 10 production lines, 370 years of combined R&D engineer experience, 50 quality-control staff, and ISO9001, ISO14001, and ISO45001 certifications. Export sales represent 31%–40% of total sales, with exporting reported since 2020 in one record and since 1998 in the company description, creating a discrepancy. Trade records show limited documented transactions and associated buyers in Bolivia, India, and Vietnam. Evidence is insufficient to assess after-sales service, financial credibility, customization, or verified customer performance comprehensively.

Supplier typeThe supplier is identified as a limited company and pharmaceutical manufacturer based in Shandong, China. Its stated products include injectable cephalosporins and penicillins, oral solid medicines, lyophilized products, and veterinary medicines, indicating a combined manufacturing and commercial business profile.

CertificationsThe supplier reports ISO9001:2015, ISO14001:2015, and ISO45001:2016 management-system certificates, along with cGMP, PIC/S, and ANVISA GMP holdings. These claims directly support established quality, environmental, occupational-safety, and pharmaceutical GMP capability, although certificate validity and scope are not independently shown.

R&D capabilityThe supplier reports 370 years of total R&D engineer experience and offers multiple dosage forms and pharmaceutical categories, including lyophilized products and injectable antibiotics. These details support R&D resources and product-development breadth, but no information confirms proprietary technologies, new product launches, patents, or development outcomes.

Production capacityProduction capability is supported by 4,950 employees, more than 10 production lines, pharmaceutical manufacturing descriptions, and product records for injectable antibiotics and veterinary cefotaxime sodium sterile. The plant-area entry is recorded as 0.0m², which is unusable or inconsistent data, so facility scale cannot be confirmed from that field.

Client casesTrade-related records associate the supplier with buyers in Bolivia, India, and Vietnam and show documented transactions for oral rehydration products, cefotaxime acid, and ceftriaxone sodium for injection. The records show some international commercial activity, but the number of stated transactions is limited and no customer testimonials, repeat-order evidence, or performance evaluations are provided.

Product Q&A

Q:What are the main clinical applications of Cefazolin Sodium for Injection?

It is suitable for treating infections caused by sensitive bacteria, including otitis media, bronchitis, pneumonia, urinary tract infections, skin and soft tissue infections, bone and joint infections, septicemia, infectious endocarditis, and hepatobiliary system infections. It can also be used as preventive medicine before surgery.

Q:What certifications does Reyoung Pharma hold?

Reyoung Pharma is an enterprise authenticated by GMP, ISO9001, ISO14001, and OHS18001. It has also passed GMP inspections in countries such as Colombia, Peru, Congo, Ethiopia, Uganda, Nigeria, Ghana, Tanzania, Kenya, Cote d'Ivoire, Pakistan, Ukraine, Philippines, and Cambodia.

Q:What is the annual production capacity of the manufacturer?

The annual production capacity includes 2.5 billion vials of powder for injection, 300 million ampoules of liquid injection, 4 billion tablets, 6 billion capsules, 200 million bags of granule solid formulation, and 2000 tons of API.

Q:Which markets do the products export to?

Products are exported to more than 70 countries worldwide, covering Asia, South America, Africa, CIS Countries, the Middle East, and Europe, including Thailand, Philippines, Cambodia, Hong Kong, Vietnam, India, Pakistan, Colombia, Peru, Chile, Costa Rica, Venezuela, Congo, Ethiopia, Uganda, Nigeria, Tanzania, Kenya, Cameroon, Russia, Kazakhstan, Ukraine, Uzbekistan, Georgia, Yemen, Iraq, Germany, and Denmark.

Q:Does the company offer OEM or ODM services?

Yes, the company offers both OEM and ODM services. Certificates such as GMP, SGS, and ISO are available for customization.